Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Tau protein concentrations in the cerebrospinal fluid of children with acute disseminated encephalomyelitis.
The Prevalence of the Classical and non-Classical Cardiovascular Risk Factors in Multiple Sclerosis Patients.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
Bone health and multiple sclerosis.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
Silencing IFN-γ Binding/Signaling in Astrocytes versus Microglia Leads to Opposite Effects on Central Nervous System Autoimmunity.
Reducing falls and improving mobility in multiple sclerosis.
Hypoxia Inducible Factor-1α in Astrocytes and/or Myeloid Cells Is Not Required for the Development of Autoimmune Demyelinating Disease(,.)
The DNA Copy Number of Human Endogenous Retrovirus-W (MSRV-Type) Is Increased in Multiple Sclerosis Patients and Is Influenced by Gender and Disease Severity.
Alemtuzumab treatment of multiple sclerosis.
Inflammation high-field magnetic resonance imaging.
Time-Domain and Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer in MS Patients and Healthy Controls.
Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neuromyelitis Optica.
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]
Fingolimod Therapy and Macular Hemorrhage.
Primary varicella zoster infection associated with fingolimod treatment.
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis.
The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis.
Exome sequencing to find rare variants causing neurologic diseases.
Current and emerging therapies in multiple sclerosis: a systematic review.
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.

Pages